Intensive lipid lowering with atorvastatin in patients with stable coronary disease Academic Article uri icon

Overview

MeSH Major

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Coronary Disease
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles

abstract

  • Intensive lipid-lowering therapy with 80 mg of atorvastatin per day in patients with stable CHD provides significant clinical benefit beyond that afforded by treatment with 10 mg of atorvastatin per day. This occurred with a greater incidence of elevated aminotransferase levels.

publication date

  • April 7, 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa050461

PubMed ID

  • 15755765

Additional Document Info

start page

  • 1425

end page

  • 35

volume

  • 352

number

  • 14